Companion Diagnostic Market Report


   October 18, 2019
According to a new market report published by Lucintel, the future of the companion diagnostic market looks promising with opportunities in the pharmaceutical and biopharmaceutical companies and reference laboratories. The companion diagnostic market is expected to grow with a CAGR of 20% from 2019 to 2024. The major drivers for this market are improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence, and increasing collaborations and partnerships for companion diagnostic test development.

Free customization on reports https://www.lucintel.com/companion-diagnostic-market.aspx

Within the companion diagnostic market, oncology and neurology are the major segment by indication. The oncology segment is the largest segment of the companion diagnostic market.

Polymerase chain reaction (PCR), immunohistochemistry (IHC), In situ hybridization (ISH), and next-generation sequencing are the major technology segment of the companion diagnostic market.

Download Free PDF Brochure @ https://www.lucintel.com/companion-diagnostic-market.aspx#/

North America will remain the largest region over the forecast period due to increasing technological advancements aimed at developing companion diagnostic tests for new indications such as neurology, infectious diseases, and so on.

Pre-Purchase Query @ https://www.lucintel.com/companion-diagnostic-market.aspx#/

F. Hoffmann-La Roche, Agilent Technologies, Qiagen N.V., Thermo Fisher Scientific, Abbott Laboratories, Biomérieux, Danaher Corporation, Illumina ,Myriad Genetics, Arup Laboratories, Sysmex, Hologic, Almac Group, and Abnova are among the major manufacturers of companion diagnostic.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the companion diagnostic market by product and service, technology, indication, end use, and region. Lucintel has prepared a comprehensive research report titled "Companion Diagnostic Market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the companion diagnostic    market by product and service, technology, indication, end use, and region as follows:

By Product and Service [$M shipment analysis for 2013 – 2024]:



  • Assays & Reagents


  • Software & Services


By Technology [$M shipment analysis for 2013 – 2024]:



  • Polymerase Chain Reaction (PCR)


  • Immunohistochemistry (IHC)


  • In Situ Hybridization (ISH)


  • Next-generation Sequencing


  • Other Technologies


By Indication [$M shipment analysis for 2013 – 2024]:



  • Oncology


  • Neurology


  • Others


By End Use [$M shipment analysis for 2013 – 2024]:



  • Pharmaceutical and Biopharmaceutical Companies


  • Reference Lab


  • Other End Users


By Region [$M shipment analysis for 2013 – 2024]:



  • North America


    • United States


    • Canada


    • Mexico




  • Europe


    • United Kingdom


    • Germany


    • France


    • Italy


    • Spain




  • Asia-Pacific


    • China


    • India


    • Japan




  • ROW


    • Brazil




Download Free Sample Page @ https://www.lucintel.com/companion-diagnostic-market.aspx#/

This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/companion-diagnostic-market.aspx or helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.



Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Market Research Reports

Aerospace & Defense [51]
Chemical [258]
Composites & Advanced Materials [160]
Construction & Industrial [68]
Consumer and Retail [120]
Economic Analysis [86]
Energy & Utility [73]
Finance & Services [10]
Healthcare [62]
Media & Entertainment [16]
Metals & Mining [17]
Technology & Telecommunication [162]
Transportation [140]

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti

Quick Query

Lucintel Insights in News

Follow us on